IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates

Company Performance - IQVIA reported quarterly earnings of $2.64 per share, exceeding the Zacks Consensus Estimate of $2.58 per share, and up from $2.43 per share a year ago [9] - The company posted revenues of $3.81 billion for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 0.69%, and compared to revenues of $3.73 billion in the same quarter last year [4] - IQVIA has surpassed consensus EPS estimates four times over the last four quarters [10] Market Comparison - IQVIA shares have declined approximately 2.9% since the beginning of the year, while the S&P 500 has gained 15.4% [5] - The Zacks Medical - Instruments industry, to which IQVIA belongs, is currently ranked in the bottom 44% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [12] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $2.81 on revenues of $3.86 billion, and for the current fiscal year, it is $11.07 on revenues of $15.44 billion [7] - The estimate revisions trend for IQVIA is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6][11]